In this study we investigated the role of IGF2 in this liver phenotype and showed that loss of IGF2 reduced liver inflammation and fibrosis, but not steatosis, in mice lacking SRSF3 in hepatocytes. The gene discussed is SRSF3; the disease is steatosis.